Brief: Guardant Health Q2 Adjusted EPS USD -0.48 Vs. IBES Estimate USD -0.74
07/08/2024 21:05
Aug 07 (Reuters) - Guardant Health Q2 revenue USD 177.2 million vs. IBES estimate USD 162.7 million. * Q2 adjusted net income USD -58.5 million vs. IBES estimate USD -94.4 million * Q2 EPS USD -0.84 * Q2 adjusted EBITDA USD -61.9 million vs. IBES estimate USD -76.3 million * outlook FY revenue USD 690-700 million
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte